Personalized and Regenerative Medicine for Liver Diseases.
Regeneration of diseased organ is a ubiquitous clinical need. The clinical utilities of adult stem cells and microRNA have become a promising strategy for treatment of a number disease. This review aims to highlight the current clinical evidence of personalized and regenerative therapy for diseases like liver which could revolutionize patient care in the near future at a global scale. Herein, we explain the importance of personalized and regenerative medicine for bedside (intraoperative) in situ and In vivo regeneration of damaged organ/ tissues that is now being transferred to a larger field of clinical applications in a novel translational approach.
Shibashish
S
Giri
Applied Stem Cell Biology and Cell Technology, Biomedical and Biotechnological Center (BBZ), Medical faculty, Universität Leipzig, Deutscher Platz 5, D-04103 Leipzig, Germany.
Augustinus
A
Bader
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis / Q000628:therapy*; D008115:Liver Regeneration; D057285:Precision Medicine; D044968:Regenerative Medicine; D033581:Stem Cell Transplantation